Literature DB >> 22632441

An increase in ALS incidence on the Kii Peninsula, 1960-2009: a possible link to change in drinking water source.

Tameko Kihira1, Sohei Yoshida, Tetsuya Kondo, Keiko Iwai, Sachiko Wada, Satomi Morinaga, Yoshinori Kazimoto, Tomoyoshi Kondo, Kazusi Okamoto, Yasumasa Kokubo, Shigeki Kuzuhara.   

Abstract

We investigated changes in the incidence of amyotrophic lateral sclerosis (ALS) in the Koza/Kozagawa/Kushimoto area (K. area) in the Kii Peninsula, Japan in 1960-2009. Probable and definite ALS cases diagnosed using El Escorial criteria were collected during a five-decade period: period I-V, 1960-2009. Forty-three ALS patients matched the selection criteria in the overall K. area, including three patients on Oshima, a small island opposite the mainland K. area. The age- and gender-adjusted incidence of ALS in the overall K. area (standardized for the 2005 Japanese population) decreased from 5.47/100,000 (95% CI 1.86-9.08) in period I to 0.61/100,000 (95% CI-0.28-1.50) in period III, and then increased to 4.39/100,000 (95% CI 1.70-7.07) in period V. On Oshima, the age- and gender-adjusted incidence of ALS was 9.45/100,000 (95% CI-7.39-26.29) in period V. The present research indicates an increase of ALS incidence in the K. area, especially on Oshima. A limitation of this study was the small population.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22632441      PMCID: PMC3409458          DOI: 10.3109/17482968.2012.674140

Source DB:  PubMed          Journal:  Amyotroph Lateral Scler        ISSN: 1471-180X


Introduction

Amyotrophic lateral sclerosis (ALS) is a devastating adult-onset degenerating disease of unknown etiology of the motor neuron systems. The Koza, Kozagawa and Kushimoto (K.) area in the Kii Peninsula of Japan was reported to have a higher incidence of ALS in the 1950s than other areas of the world (1–5). Epidemio-logic research showed that drinking water sourced from Kozagawa River in the K. area contained severely low levels of Ca and Mg, and Ca/Mg deficiency was speculated to have a role in the development of ALS in these areas (5,6). On Oshima, a small island municipally included in the K. area, the source of drinking water was changed from regional water to the Kozagawa River in 1975. To clarify whether ALS epidemiology on Oshima changed after altering the water source, we investigated changes in ALS incidence on Oshima and in the K. area in 1960–2009.

Methods

Area of investigation

The K. area (population: 23,357 in 2005 census, 430.3 km2) is located in the southern part of Wakayama Prefecture of the Kii peninsula, Japan (Figure 1). Oshima (population: 1279 in 2005 census, 9.93 km2) is an island opposite the K. area. The K. area has a local public healthcare and welfare center, two local public hospitals, two private hospitals and 19 medical clinics.
Figure 1

Geography of Koza/Kozagawa/Kushimoto area and Oshima, and distribution of patients with ALS. Patients with ALS between 1960 and 1969 (period I: º), between 1970 and 1979 (period II: Δ): between 1980 and 1989 (period III: □), between 1990 and 1999 (period IV: ☆), and between 2000 and 2009 (period V: •) were plotted. *: ALS/PDC

Geography of Koza/Kozagawa/Kushimoto area and Oshima, and distribution of patients with ALS. Patients with ALS between 1960 and 1969 (period I: º), between 1970 and 1979 (period II: Δ): between 1980 and 1989 (period III: □), between 1990 and 1999 (period IV: ☆), and between 2000 and 2009 (period V: •) were plotted. *: ALS/PDC

Incidence of ALS in 1960–2009

ALS patients on Oshima and overall in the K. area were enrolled from multiple sources, including hospital medical records and reports from local medical staff over a five-decade period: period I, 1960–1969; period II, 1970–1979; period III, 1980–1989; period IV, 1990–1999; period V, 2000–2009. Regional physicians including neurologists in hospitals and clinics and the staff of the public healthcare and welfare center in the K. area were requested by our team to report all patients with possible motor neuron disease every year (7). To ensure complete case identification, Wakayama Prefecture's List of Patients with Intractable Disease certified by the Ministry of Health and Welfare of Japan was used. The selection criteria were as follows: 1) patients who our neurologists examined and diagnosed using the El Esco-rial criteria (8); 2) patients with probable or definite ALS who had been living in the K. area, including Oshima, for at least one year before diagnosis. Patients who showed Parkinsonism or dementia during the disease course (ALS/Parkinsonism dementia complex: ALS/PDC) were also included. The present research was approved by the ethics committee of Wakayama Medical University and Kansai University of Health Sciences.

Statistics

A direct method was used to standardize the annual incidence rates by age and gender, using populations in the 2005 census in Japan: 127,537,189. Unpaired t-test was performed and two-sided p<0.05 was considered significant.

Results

Patient population and clinical characteristics

We enrolled 50 patients with definite or probable ALS in the K. area, including Oshima, in 1960–2009, and 43 patients matched the selection criteria (Table I) (seven were excluded because they were living outside the K. area when diagnosed). Patient distribution was restricted to the mainland side of the K. area during periods I-IV. Three ALS patients were found on Oshima (two males and one female) in period V (Figure 1).
Table I

Patients with ALS in the K. area, including Oshima in each period.

Population&ALS patients matched for the selection criteria
PeriodOverall K areaOshimaTotal ALS patients enrolled (»)Overall K areaOshimaAge at onset Mean (S.D.)M/F ratioFH n (%)
I18,251#2,82377056.1 (10.8)2.50(0)
II32,1282,0951210055.3 (10.6)1.51 (10)
III29,7321,75642059.0 (7.1)2.00(0)
IV26,4051,508119057.7 (11.5)2.03 (33)
V23,3571,2791615367.6 (12.3)*0.882(13)
Total504331.536 (14.0)

K.: Koza/Kozagawa/Kushimoto area; M/F: male/female ratio; FH: familial history.

: populations in 1965, 1975, 1985, 1995 and 2005 census.

: Koza/Kozagawa area.

: £<0.01 when compared with the mean age at onset in period I.

Patients with ALS in the K. area, including Oshima in each period. K.: Koza/Kozagawa/Kushimoto area; M/F: male/female ratio; FH: familial history. : populations in 1965, 1975, 1985, 1995 and 2005 census. : Koza/Kozagawa area. : £<0.01 when compared with the mean age at onset in period I. The mean age at onset in period V was the highest among the periods (Table I). The male: female ratio was low in period V compared to periods I-IV. The frequency of cases with a positive familial history in a detailed interview was 14.0%. Cu/Zn super-oxide dismutase (SOD1) genes were analyzed in three of six familial cases; none had a SOD1 gene mutation. Three ALS/PDC patients were found in the K. area in period IV and one patient on Oshima in period V. The mean annual crude ALS incidence in the K. area in period V was 6.42/100,000 and that on Oshima was 23.46/100,000. The age- and gender-adjusted ALS incidence in the K. area decreased from 5.47/100,000 (95% CI 1.86–9.08) in period I to 0.61/100,000 (95% CI-0.28–1.50) in period III and then increased to 4.39/100,000 (95% CI 1.70–7.07) in period V (Figure 2). On Oshima, the age-and gender-adjusted incidence of ALS was 9.45/100,000 (95% CI-7.39–26.29) in period V.
Figure 2

Changes in incidence of ALS in the overall Koza/Kozagawa/Kushimoto (K.) area and Oshima between 1960 and 2009. Comparing the incidence by the periods, the age- and gender-adjusted incidence of ALS in the overall K. area for the 2005 Japanese population was 5.47/100,000 (95% CI 1.86–9.08), male: 8.29/100,000 (95% CI 1.84–14.73), female: 2.98/100,000 (95% CI-0.69–6.66) in period I, markedly decreased to 0.61/100,000 (95% CI-0.28–1.50), male: 1.36/100,000 (95% CI-0.58–3.30), female: 0 in period III, but recently increased again to 4.39/100,000 (95% CI 1.70–7.07), male: 4.01/100,000 (95% CI 0.22–7.81), female: 4.71/100,000 (95% CI 0.93–8.49) in period V.

Changes in incidence of ALS in the overall Koza/Kozagawa/Kushimoto (K.) area and Oshima between 1960 and 2009. Comparing the incidence by the periods, the age- and gender-adjusted incidence of ALS in the overall K. area for the 2005 Japanese population was 5.47/100,000 (95% CI 1.86–9.08), male: 8.29/100,000 (95% CI 1.84–14.73), female: 2.98/100,000 (95% CI-0.69–6.66) in period I, markedly decreased to 0.61/100,000 (95% CI-0.28–1.50), male: 1.36/100,000 (95% CI-0.58–3.30), female: 0 in period III, but recently increased again to 4.39/100,000 (95% CI 1.70–7.07), male: 4.01/100,000 (95% CI 0.22–7.81), female: 4.71/100,000 (95% CI 0.93–8.49) in period V.

Discussion

The age- and gender-adjusted ALS incidence in the K. area decreased from 5.47 in 1960–1969 to 0.61 in 1980–1989, and then increased to 4.39 in 2000–2009. The declining trend of the male: female ratio in the past 10 years was comparable with other reports (9,10), and the recent increase of ALS incidence in females could be related to some type of environmental or cultural factor pertaining in females in this area and the increased confirmation of older female patients (11). The reason for the decline in 1980-1989 is not clear, but might be partially due to missing cases from the data set, emigration, and environmental, lifestyle and cultural changes. Recent reports of annual age-adjusted ALS incidences ranged from 0.42/100,000 (12) to 2.96/100,000 (13) in other areas in the world (14–17). Taken together, the age-and gender-adjusted incidence in the K. area and Oshima in 2000-2009 was higher than in other areas. On Oshima, no patient with ALS was found in previous research in 1946–1965 (18). It is noteworthy that a high ALS incidence was first found on Oshima in 2000–2009 after the drinking water source was changed to the Kozagawa River in 1975. The present research indicated an increase of ALS incidence in the K. area, especially on Oshima. A limitation of this study was the small population. Continuous study over a longer period is needed in this area.
  16 in total

1.  Changes in the incidence of amyotrophic lateral sclerosis in Wakayama, Japan.

Authors:  Tameko Kihira; Sohei Yoshida; Masaya Hironishi; Hideto Miwa; Kazusi Okamato; Tomoyoshi Kondo
Journal:  Amyotroph Lateral Scler Other Motor Neuron Disord       Date:  2005-09

2.  [Epidemiological study on amyotrophic lateral sclerosis (ALS) and other neighboring motor neuron diseases in Kii Peninsula].

Authors:  K KUSUI
Journal:  Seishin Shinkeigaku Zasshi       Date:  1962-01-25

Review 3.  Studies of amyotrophic lateral sclerosis in the Kozagawa district of the Kii peninsula, Japan. (epidemiological, genealogical and environmental studies).

Authors:  K Kimura
Journal:  Wakayama Med Rep       Date:  1965-03

4.  Motor neuron disease in the Kii peninsula, Japan.

Authors:  Y Yase; N Matsumoto; F Yoshimasu; Y Handa; T Kumamoto
Journal:  Proc Aust Assoc Neurol       Date:  1968

5.  Epidemiology of amyotrophic lateral sclerosis in Isfahan, Iran.

Authors:  M Sajjadi; M Etemadifar; A Nemati; H Ghazavi; K Basiri; B Khoundabi; S A Mousavi; P Kabiri; A H Maghzi
Journal:  Eur J Neurol       Date:  2010-02-28       Impact factor: 6.089

6.  El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial "Clinical limits of amyotrophic lateral sclerosis" workshop contributors.

Authors:  B R Brooks
Journal:  J Neurol Sci       Date:  1994-07       Impact factor: 3.181

7.  Incidence and prevalence of ALS in Ireland, 1995-1997: a population-based study.

Authors:  B J Traynor; M B Codd; B Corr; C Forde; E Frost; O Hardiman
Journal:  Neurology       Date:  1999-02       Impact factor: 9.910

Review 8.  Incidence and prevalence of amyotrophic lateral sclerosis in Canada: a systematic review of the literature.

Authors:  C Wolfson; S Kilborn; M Oskoui; A Genge
Journal:  Neuroepidemiology       Date:  2009-05-30       Impact factor: 3.282

9.  Epidemiology of ALS in Padova district, Italy, from 1992 to 2005.

Authors:  V Cima; G Logroscino; C D'Ascenzo; A Palmieri; M Volpe; C Briani; E Pegoraro; C Angelini; G Soraru
Journal:  Eur J Neurol       Date:  2009-03-31       Impact factor: 6.089

10.  The sex ratio in amyotrophic lateral sclerosis: A population based study.

Authors:  Zita R Manjaly; Kirsten M Scott; Kumar Abhinav; Lokesh Wijesekera; Jeban Ganesalingam; Laura H Goldstein; Anna Janssen; Andrew Dougherty; Emma Willey; Biba R Stanton; Martin R Turner; Mary-Ann Ampong; Mohammed Sakel; Richard W Orrell; Robin Howard; Chris E Shaw; P Nigel Leigh; Ammar Al-Chalabi
Journal:  Amyotroph Lateral Scler       Date:  2010-10
View more
  8 in total

Review 1.  Clinical and demographic factors and outcome of amyotrophic lateral sclerosis in relation to population ancestral origin.

Authors:  Benoît Marin; Giancarlo Logroscino; Farid Boumédiene; Anaïs Labrunie; Philippe Couratier; Marie-Claude Babron; Anne Louise Leutenegger; Pierre Marie Preux; Ettore Beghi
Journal:  Eur J Epidemiol       Date:  2015-10-12       Impact factor: 8.082

Review 2.  Current pathways for epidemiological research in amyotrophic lateral sclerosis.

Authors:  Pam Factor-Litvak; Ammar Al-Chalabi; Alberto Ascherio; Walter Bradley; Adriano Chío; Ralph Garruto; Orla Hardiman; Freya Kamel; Edward Kasarskis; Ann McKee; Imaharu Nakano; Lorene M Nelson; Andrew Eisen
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2013-05       Impact factor: 4.092

Review 3.  Global epidemiology of amyotrophic lateral sclerosis: a systematic review of the published literature.

Authors:  A Chiò; G Logroscino; B J Traynor; J Collins; J C Simeone; L A Goldstein; L A White
Journal:  Neuroepidemiology       Date:  2013-07-11       Impact factor: 3.282

4.  An exploratory spatial analysis of ALS incidence in Ireland over 17.5 years (1995-July 2013).

Authors:  James Rooney; Mark Heverin; Alice Vajda; Arlene Crampsie; Katy Tobin; Susan Byrne; Anthony Staines; Orla Hardiman
Journal:  PLoS One       Date:  2014-05-27       Impact factor: 3.240

5.  Lifestyle Changes and Oxidative Stress in a High-incidence Area of Amyotrophic Lateral Sclerosis in the Southwestern Kii Peninsula, Japan.

Authors:  Tameko Kihira; Kazushi Okamoto; Iori Sakurai; Yuya Arakawa; Ikuro Wakayama; Koichi Takamiya; Ryo Okumura; Yuhto Iinuma; Keiko Iwai; Yasumasa Kokubo; Sohei Yoshida
Journal:  Intern Med       Date:  2017-06-15       Impact factor: 1.271

Review 6.  Therapeutic Strategies and Metal-Induced Oxidative Stress: Application of Synchrotron Radiation Microbeam to Amyotrophic Lateral Sclerosis in the Kii Peninsula of Japan.

Authors:  Sohei Yoshida
Journal:  Front Neurol       Date:  2022-06-28       Impact factor: 4.086

7.  Amyotrophic lateral sclerosis and parkinsonism in Papua, Indonesia: 2001-2012 survey results.

Authors:  Kiyohito Okumiya; Taizo Wada; Michiko Fujisawa; Masayuki Ishine; Eva Garcia Del Saz; Yutaka Hirata; Shigeki Kuzuhara; Yasumasa Kokubo; Harumichi Seguchi; Ryota Sakamoto; Indrajaya Manuaba; Paulina Watofa; Andreas L Rantetampang; Kozo Matsubayashi
Journal:  BMJ Open       Date:  2014-04-16       Impact factor: 2.692

Review 8.  Variation in worldwide incidence of amyotrophic lateral sclerosis: a meta-analysis.

Authors:  Benoît Marin; Farid Boumédiene; Giancarlo Logroscino; Philippe Couratier; Marie-Claude Babron; Anne Louise Leutenegger; Massimilano Copetti; Pierre-Marie Preux; Ettore Beghi
Journal:  Int J Epidemiol       Date:  2017-02-01       Impact factor: 7.196

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.